Currently in force / active
Posted: Sun Aug 09, 2026 11:31 pm
| Jurisdiction | Regulation | Key Date | Status | Description |
| United States (NY, insurers) | NYDFS Circular Letter No. 7 | In force since July 11, 2024 | Active | Requires insurers using AI in underwriting/pricing to maintain governance frameworks, board oversight, and third-party vendor due diligence |
| Texas | TRAIGA (HB 149) | Effective January 1, 2026 | Active | Bans specific AI uses (self-harm incitement, CSAM deepfakes, government social scoring); requires state agency AI-use disclosure |
| California | SB 53 (Transparency in Frontier AI Act) | Effective January 1, 2026 | Active | Frontier AI developer transparency obligations |
| United States (insurance market) | Verisk/ISO standardized GenAI exclusions | Effective January 1, 2026 | Active | Standard commercial liability policy language now excludes generative AI-related claims by default |
| South Korea | AI Basic Act - Enforcement Decree | In force since January 22, 2026 | Active, penalties deferred | Requires named responsible manager and interruption/rollback mechanisms for high-impact AI systems |
| European Union | AI Act - Article 50 transparency obligations | In force since August 2, 2026 | Active | Requires disclosure when users interact with AI systems or are exposed to AI-generated/manipulated content |
| California | AI Transparency Act (SB 942/AB 853) | In force since August 2, 2026 (delayed from Jan 1, 2026) | Active | Requires AI-content detection tools and watermarking on qualifying platforms |
| European Union | AI Act - Regulation (EU) 2026/1744 (Digital Omnibus) | In force since July 27, 2026 | Regulation in force; high-risk obligations deferred | Annex III standalone high-risk obligations deferred to December 2, 2027; Annex I embedded high-risk deferred to August 2, 2028; Article 50 transparency unchanged (August 2, 2026), except the watermarking sub-obligation and new Article 5 NCII/CSAM prohibition, both deferred to December 2, 2026 |